Skip to Main Content

Paper Details

Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Mol Carcinog
23
2017
Author NameAffiliation
Stefan W??lflInstitute of Pharmacy and Molecular Biotechnology, University of Heidelberg
  • 1 - 1

Datasets

Release 1.2